IS7501A - thurrdufts innöndunar samsetning - Google Patents
thurrdufts innöndunar samsetningInfo
- Publication number
- IS7501A IS7501A IS7501A IS7501A IS7501A IS 7501 A IS7501 A IS 7501A IS 7501 A IS7501 A IS 7501A IS 7501 A IS7501 A IS 7501A IS 7501 A IS7501 A IS 7501A
- Authority
- IS
- Iceland
- Prior art keywords
- dry powder
- powder inhalation
- inhalation composition
- composition
- dry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0208609.8A GB0208609D0 (en) | 2002-04-13 | 2002-04-13 | Compositions |
PCT/GB2003/001595 WO2003088944A1 (en) | 2002-04-13 | 2003-04-10 | Dry powder inhalant composition |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7501A true IS7501A (is) | 2004-10-11 |
Family
ID=9934856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7501A IS7501A (is) | 2002-04-13 | 2004-10-11 | thurrdufts innöndunar samsetning |
Country Status (19)
Country | Link |
---|---|
US (2) | US20050232998A1 (is) |
EP (1) | EP1509199A1 (is) |
JP (1) | JP2005529874A (is) |
KR (1) | KR20040097348A (is) |
CN (1) | CN100362986C (is) |
AR (1) | AR039408A1 (is) |
AU (1) | AU2003224278A1 (is) |
BR (1) | BR0309115A (is) |
CA (1) | CA2482249A1 (is) |
GB (1) | GB0208609D0 (is) |
IL (1) | IL164421A0 (is) |
IS (1) | IS7501A (is) |
MX (1) | MXPA04010082A (is) |
NO (1) | NO20044496L (is) |
PL (1) | PL373293A1 (is) |
RU (1) | RU2004130438A (is) |
TW (1) | TW200407174A (is) |
WO (1) | WO2003088944A1 (is) |
ZA (1) | ZA200408247B (is) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024396A2 (en) | 2001-09-17 | 2003-03-27 | Glaxo Group Limited | Dry powder medicament formulations |
JP2009513531A (ja) * | 2003-07-11 | 2009-04-02 | グラクソ グループ リミテッド | 糖エステルを含む吸入可能医薬製剤 |
RU2007133547A (ru) | 2005-02-10 | 2009-03-20 | Глаксо Груп Лимитед (GB) | Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции |
GB0605723D0 (en) | 2006-03-23 | 2006-05-03 | 3M Innovative Properties Co | Powder filling processes |
GB0714134D0 (en) * | 2007-07-19 | 2007-08-29 | Norton Healthcare Ltd | Dry-powder medicament |
ES2452965T3 (es) * | 2007-09-05 | 2014-04-03 | Rigel Pharmaceuticals, Inc. | Sal de xinafoato de N4-[(2,2-difluoro-4H-benzo[1,4]oxazin-3-ona)-6-il]-5-fluoro-N2-[3-(metilaminocarbonilmetilenoxi)fenil]-2,4-pirimidindiamina |
TR201007250A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Selobioz içeren formülasyon. |
TR201007251A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Kalsiyum kanal blokörü formülasyonu. |
JOP20120023B1 (ar) * | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
GB201113662D0 (en) | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
KR20200015828A (ko) * | 2012-02-28 | 2020-02-12 | 아이슈티카 홀딩스 인코포레이티드. | 흡입용 약제학적 조성물 |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
PL3517541T3 (pl) | 2012-05-08 | 2020-12-28 | Nicox Ophthalmics, Inc. | Postać polimorficzna propionianu flutykazonu |
MX354365B (es) | 2012-07-19 | 2018-02-28 | Adamis Pharmaceuticals Corp | Aparato alimentador de polvo. |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
EP2991625A1 (en) * | 2013-04-29 | 2016-03-09 | Sanofi SA | Inhalable pharmaceutical compositions and the inhaler devices containing them |
CN104644618A (zh) * | 2013-11-19 | 2015-05-27 | 上海医药工业研究院 | 一种干粉吸入剂及其制备方法 |
PL3179986T3 (pl) * | 2014-07-31 | 2023-06-26 | Vectura Inc. | Suche formulacje w proszku do inhalacji |
WO2016052897A1 (en) * | 2014-09-30 | 2016-04-07 | Hanmi Pharm. Co., Ltd. | Dry powder for inhalation formulation having improved stability of combined active ingredients |
KR20160117069A (ko) * | 2015-03-31 | 2016-10-10 | 한미약품 주식회사 | 복합 활성성분의 안정성이 개선된 흡입용 캡슐제 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR8007911A (pt) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | Inalador aperfeicoado |
SE448277B (sv) * | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
DK163640C (da) * | 1985-07-30 | 1992-08-17 | Glaxo Group Ltd | Apparat til administrering af medikamenter |
US5202309A (en) * | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
IL95590A (en) * | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
AU8229998A (en) * | 1997-07-03 | 1999-01-25 | Quadrant Holdings Cambridge Limited | Modified glycosides, compositions comprised thereof and methods of use thereof |
US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
GB9916316D0 (en) * | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
UA73965C2 (en) * | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
MXPA03004883A (es) * | 2000-12-01 | 2004-05-04 | Battelle Memorial Institute | Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas. |
AU2002234476B2 (en) * | 2001-03-30 | 2006-04-27 | Jagotec Ag | Medical aerosol formulations |
WO2003099764A1 (en) * | 2002-05-28 | 2003-12-04 | Theravance, Inc. | ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS |
-
2002
- 2002-04-13 GB GBGB0208609.8A patent/GB0208609D0/en not_active Ceased
-
2003
- 2003-04-10 CN CNB038134608A patent/CN100362986C/zh not_active Expired - Fee Related
- 2003-04-10 JP JP2003585696A patent/JP2005529874A/ja active Pending
- 2003-04-10 CA CA002482249A patent/CA2482249A1/en not_active Abandoned
- 2003-04-10 BR BR0309115-5A patent/BR0309115A/pt not_active IP Right Cessation
- 2003-04-10 MX MXPA04010082A patent/MXPA04010082A/es unknown
- 2003-04-10 WO PCT/GB2003/001595 patent/WO2003088944A1/en active Application Filing
- 2003-04-10 KR KR10-2004-7016301A patent/KR20040097348A/ko not_active Application Discontinuation
- 2003-04-10 EP EP03720702A patent/EP1509199A1/en not_active Withdrawn
- 2003-04-10 US US10/510,968 patent/US20050232998A1/en not_active Abandoned
- 2003-04-10 RU RU2004130438/15A patent/RU2004130438A/ru not_active Application Discontinuation
- 2003-04-10 PL PL03373293A patent/PL373293A1/xx unknown
- 2003-04-10 AU AU2003224278A patent/AU2003224278A1/en not_active Abandoned
- 2003-04-11 AR ARP030101279A patent/AR039408A1/es not_active Application Discontinuation
- 2003-04-11 TW TW092108404A patent/TW200407174A/zh unknown
-
2004
- 2004-10-05 IL IL16442104A patent/IL164421A0/xx unknown
- 2004-10-11 IS IS7501A patent/IS7501A/is unknown
- 2004-10-12 ZA ZA200408247A patent/ZA200408247B/xx unknown
- 2004-10-21 NO NO20044496A patent/NO20044496L/no not_active Application Discontinuation
-
2007
- 2007-11-05 US US11/934,983 patent/US20080060645A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0208609D0 (en) | 2002-05-22 |
AU2003224278A1 (en) | 2003-11-03 |
AR039408A1 (es) | 2005-02-16 |
ZA200408247B (en) | 2006-03-29 |
US20050232998A1 (en) | 2005-10-20 |
KR20040097348A (ko) | 2004-11-17 |
CN1658837A (zh) | 2005-08-24 |
BR0309115A (pt) | 2005-02-01 |
TW200407174A (en) | 2004-05-16 |
RU2004130438A (ru) | 2005-06-10 |
CN100362986C (zh) | 2008-01-23 |
NO20044496L (no) | 2004-11-15 |
PL373293A1 (en) | 2005-08-22 |
CA2482249A1 (en) | 2003-10-30 |
IL164421A0 (en) | 2005-12-18 |
WO2003088944A1 (en) | 2003-10-30 |
US20080060645A1 (en) | 2008-03-13 |
MXPA04010082A (es) | 2004-12-13 |
JP2005529874A (ja) | 2005-10-06 |
EP1509199A1 (en) | 2005-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE331550T1 (de) | Trockenpulverinhalator | |
DK3354263T3 (da) | Tørpulverformuleringer | |
ATE326251T1 (de) | Pulverinhalator | |
EP1487524A4 (en) | INHALER FOR DRY POWDER | |
ATE460955T1 (de) | Trockenpulver-inhalator | |
NO20022414D0 (no) | Tiotropium-inneholdende inhalasjonspulver | |
IS7501A (is) | thurrdufts innöndunar samsetning | |
IL174735A0 (en) | Dry powder inhaler | |
DE60310914D1 (de) | Pulverzusammensetzung | |
NO20035442D0 (no) | Pulverlakksammensetning | |
DE60221611D1 (de) | Trockenpulverinhalator | |
IS7500A (is) | thurrdufts samsetningar | |
GB0321610D0 (en) | Dry powder inhaler | |
NO20043489L (no) | Sammensetning for inhalering | |
DK1567135T3 (da) | Tiotropiumholdig pulverformulering til inhalation | |
GB0319667D0 (en) | Dry powder inhaler | |
DE10313033A8 (de) | Pulverlackzusammensetzung |